Pliant Therapeutics, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| TwoSigma | quant | 2.25M | $2.84M | 0.00% | Added+136.4% | 2026-03-31 |
| RenTech | quant | 1.85M | $2.33M | 0.00% | Added+77.2% | 2026-03-31 |
| StateStreet | passive | 253.4K | $319.31K | 0.00% | Unchanged | 2026-03-31 |
| Citadel | multi-strat | 47.1K | $59.29K | 0.00% | Added+1.1% | 2026-03-31 |
| FidelityFMR | fundamental | 524 | $660 | 0.00% | Trimmed-72.9% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-06upcoming | -0.35 | — | — |
| 2026-05-11 | -0.36 | -0.32 | +10.60% |
| 2026-03-11 | -0.38 | -0.35 | +6.53% |
| 2025-11-06 | -0.52 | -0.43 | +17.97% |
| 2025-08-07 | -0.68 | -0.71 | -4.85% |
| 2025-05-08 | -0.75 | -0.92 | -23.18% |
| 2025-03-03 | -0.96 | -0.82 | +14.15% |
| 2024-11-07 | -0.98 | -0.95 | +3.02% |
| 2024-08-07 | -0.85 | -0.92 | -8.69% |
| 2024-05-06 | -0.77 | -0.78 | -1.36% |
| 2024-02-27 | -0.82 | -0.69 | +15.67% |
| 2023-11-09 | -0.77 | -0.70 | +9.35% |
| 2023-08-09 | -0.69 | -0.70 | -1.63% |
| 2023-05-09 | -0.67 | -0.67 | — |
| 2023-03-09 | -0.70 | -0.72 | -2.86% |
| 2022-11-08 | -0.74 | -0.65 | +12.53% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| PLRX | +5.00% | -2.33% | +3.28% | -12.50% |
| XLV | +2.97% | -4.83% | -3.44% | +12.62% |
| Alpha (stock − sector) | +2.03% | +2.50% | +6.72% | -25.12% |